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Studies in yeast and mice suggest that myosin V
participates in the directed transport of a number of
distinct cargos to polarized regions of the cell; myosin
V has also been implicated in the provision of materials
for filopodial extension in neurons.
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The myosins form a superfamily of motor proteins that
generate directed movement along actin filaments in an
ATP-dependent manner. The prototypical myosin was
originally discovered as the major protein in muscle, and
recent genetic and molecular biological studies have
revealed a diverse family of myosin proteins that share a
common motor domain, but have divergent carboxy-
terminal tail regions. The muscle-type myosins are
referred to as either conventional or class II myosins; all
the others (a total of twelve distinct classes so far) are col-
lectively referred to as unconventional myosins [1], each
designated by a roman numeral based on their order of
discovery. Our understanding of the roles of the uncon-
ventional myosins has lagged well behind that of the well-
studied myosin II, but rapid progress has recently been
made in defining the in vivo functions of myosin V.
Myosin V was first identified in actomyosin precipitates
from brain tissue [2] as a 190 kDa calmodulin-binding
protein that exhibits all of the expected enzymatic proper-
ties of a myosin molecule, in that it has actin-stimulated
Mg-ATPase activity and can generate directed movement
along actin cables [3,4]. Myosin V is actually an oligomer,
comprising two ~190 kDa ‘heavy chain’ subunits and
twelve low molecular weight subunits (light chains). The
light chains bind to six IQ motifs in the neck region of
each heavy chain, and the heads of the heavy chains are
correspondingly elongated relative to those of myosin II
[4]. Eight of the twelve myosin V light chains are calmod-
ulin molecules, and the other four remain to be identified.
The tail region of the myosin V heavy chain has a central
coiled-coil domain that presumably promotes dimer
formation followed by a globular domain. Unlike myosin
II, myosin V does not appear to form filaments. 
A range of roles for myosin V in yeast
The phenotypic defects observed in mice and yeast
myosin V mutants strongly suggest that this motor protein
plays a part in intracellular transport. There are two yeast
class V myosins, Myo2p and Myo4p, each of which appears
to have a distinct intracellular role. The temperature-sensi-
tive Myo2p mutant, myo2-66, undergoes growth arrest with
the formation of large unbudded cells at the restrictive tem-
perature. The cell wall is also affected by the myo2-66 muta-
tion, as evidenced by chitin delocalization [5]. Additionally,
small vesicles of unknown origin are observed to accumu-
late in the mother cell [5,6], suggestive of a defect in vesicle
transport. Cortical actin patches are still present, but they
are uniformly distributed throughout the cell instead of
being localized to the growing bud, and the actin cables
appear to have coalesced into a prominent actin bar [5].
The directed transport of Chs3p, a chitin synthase, to sites
of polarized growth is also impaired in myo2-66 mutant
cells, whereas that of another chitin synthase, Chs5p, is
unaffected [7], suggesting that myosin V is required for
the directed transport of a distinct subset of molecules.
The myo2-66 mutation additionally has profound effects
on the inheritance of the vacuole (the yeast equivalent of
the lysosome) [8]. The growing bud does not receive a
vacuole from the mother cell, suggesting that Myo2p plays
a role in the transport of this organelle into the bud [8]. All
of these defects implicate Myo2p in the directed move-
ment of distinct vesicles to the site of polarized growth in
yeast. The phenotype of the mutant and the localization
of Myo2p to the tip of growing bud [8–10] are both consis-
tent with Myo2p either organizing the actin tracks at the
tip or accumulating at the tip following its directed
translocation along those filaments to the emerging bud. 
Surprisingly, yeast Myo4p appears to play a different role
to Myo2p. Deletion of MYO4 does not result in any of the
striking abnormalities found in the myo2-66 strain [11].
However, Myo4p is required for the asymmetric accumu-
lation of the protein Ash1p in the growing bud [12]; Ash1p
represses the transcription of the HO gene, which is
required to stop the switching of mating type. By prevent-
ing Ash1p transport to the bud, loss of Myo4p thus allows
the daughter cell to express HO and switch mating types
[12,13]. The lack of alterations in either the actin
cytoskeleton, the morphology or the growth of the myo4
cells demonstrates that Myo4p plays a specialized role in
the directed transport of a component(s) required for regu-
lating gene expression. 
Myo4p is itself localized to the growing bud, and this local-
ization is dependent on either She3p or Bni1p, proteins
also implicated in the repression of HO expression in the
emerging bud [13], indicating that this myosin may be part
of a complex of proteins that are targeted to the bud.
Intriguingly, ASH1 mRNA is also localized to the growing
bud in an Myo4p-dependent manner [14], suggesting that
Myo4p may participate in a specialized transport complex
that is specific for the movement of mRNA molecules
rather than proteins. Thus, even though Myo2p and
Myo4p share many structural attributes, and have similar
intracellular localizations [11,13], these two myosins clearly
play distinct roles in directing the movement of mem-
branes, molecules or mRNA within the yeast cell (Fig. 1).
A role for myosin V in melanocytes and the nervous system
There is a well-known mutant mouse where the defect
has been shown to be in myosin V — this is the dilute
mutant, which has a lightened coat color and dies of
nervous seizures three weeks after birth [15,16]. The
overall structure of the brain from a dilute mouse appears
to be normal, as does the morphology and cytoskeletal
organization of superior cervical ganglion cells cultured
from these mice [17]. These findings suggest that the
defects in the dilute mice are the result of abnormalities in
the intracellular function of their neurons. Support for this
hypothesis has been provided by electron microscopic
analysis of sections of brains from dilute mice, which have
revealed that the usual extensions of the smooth endo-
plasmic reticulum into the dendritic spines of Purkinje
cells are absent [18]. It has also been shown that myosin V
is associated with synaptic vesicles [19], and it is likely
that this motor plays a role in the actin-dependent move-
ment of membranes — possibly vesicles carrying neuro-
transmitters — to the extremities of neurons. 
These findings echo the analyses of melanocytes cultured
from dilute mice and the distribution of myosin V in
normal melanocytes. The distribution of melanosomes is
altered in primary cultures of dilute melanocytes, whereas
the overall morphology of the cells appears normal [20].
Additionally, in wild-type mice myosin V colocalizes with
melanosomes, as well as other membrane-bound
organelles in normal melanocytes [20,21]. Subcellular frac-
tionation experiments also demonstrate that myosin V is
associated with melanosomes [21]. Taken together, these
observations suggest that myosin V functions in the
directed movement of membrane-bound organelles in
both neurons and melanocytes.
The known biochemical properties of myosins appear to
be inconsistent with the view that myosin V plays a part in
organelle transport. Detailed analyses of myosin I and II
indicate that these proteins are ‘short-duty’ motors [22], in
other words, they are not processive motors, but are
detached from actin for most of their ATP-hydrolysis
cycle. Myosin I and II therefore differ from kinesin, a
microtubule motor protein that spends most of its
hydrolytic cycle bound to microtubules. The kinetic prop-
erties of kinesin permit it to function as a transport motor
at the level of a single molecule, because it will not be
released from its track during the hydrolysis cycle. A
single myosin molecule, on the other hand, is likely to
diffuse away from an actin filament under motile condi-
tions. However, analysis of the enzymatic properties of
myosin V reveals that it may have different kinetic proper-
ties from class I and II myosins. Unlike myosin I and II, a
significant proportion of myosin V remains bound to actin
in the presence of millimolar amounts of Mg-ATP [23].
This suggests that myosin V may be able to bind to actin
for a significant amount of its hydrolysis cycle and func-
tion as a processive motor in a similar way to kinesin. 
A novel approach to exploring myosin V function
The role of myosin V in growth cone and filopodial
dynamics was explored in neuronal growth cones of the
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Figure 1
A summary of the possible roles of the two yeast myosin V molecules.
Both parts show a budding yeast cell with actin patches (green dots)
at the growing bud tip and actin cables (green lines) extending from
the bud into the mother cell. (a) A speculative model for the role of
Myo2p. This myosin molecule is attached either to membrane-bound
vesicles of unknown origin, to vacuolar membrane, or to vesicles
containing the chitin synthase Chs3p. (b) The role of Myo4p in the
directed transport of ASH1 mRNA to the growing bud is shown. The
ASH1 mRNA is depicted as part of an mRNA-binding protein complex.
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dorsal root ganglion (DRG) using micro-chromophore-
assisted laser inactivation (CALI; [24]). The results of this
study suggest that myosin V has yet another function in
vivo. The CALI technique allows for the immediate inac-
tivation of a target protein in situ by microinjection of a
non-inhibitory ‘anti-target’ antibody coupled to a chro-
mophore (typically malachite green, MG) and subsequent
application of a laser pulse at 620 nm. It is thought that
the laser treatment results in the production of short-lived
hydroxyl radicals from the MG chromophore, which then
inflict damage to proteins in close proximity (presumably
the target immunogen) without affecting neighboring pro-
teins [25]. The efficacy of this method depends on the
availability of a specific, non-inhibitory antibody and it is
necessary to demonstrate first that CALI can inactivate
the target protein in vitro. 
Microinjection of MG-labelled myosin V antibodies into
chick DRGs followed by laser irradiation had unpredicted
effects [24]. The irradiated regions of the DRG were
observed to exhibit significantly decreased rates of filopo-
dial extension. During the period of laser irradiation of the
DRGs, the filopodia were almost exclusively retracting;
however, the rate of retraction in the treated growth cones
did not significantly differ from that observed in untreated
or mock-treated DRGs. Thus, the loss of myosin V only
affects the extension of the filopodia, indicating that
myosin V is providing materials that are specifically
required for the extension of filopodia. This could be
accomplished in a direct manner by feeding the necessary
amounts of membrane to the peripheral regions of the cell
or by indirectly transporting or stabilizing other molecules
that are necessary for this process. 
The CALI results are in apparent conflict with the finding
that the overall brain structure in dilute mice is normal and
that the superior cervical ganglion cells from these mice
also appear to be normal in morphology and cytoskeletal
distribution [16,17]. This suggests that either the CALI
method is not as specific in vivo as it appears to be in vitro,
or the dilute mouse has been able to overcome what would
be a catastrophic loss of myosin V by the altered expres-
sion of another cytoskeletal protein(s). A second mouse
myosin V gene, myr6, has been identified [26], and it is
possible that altered expression of myr6 could compensate
for the loss of the other myosin V in the dilute mice.
However, even if expression of myr6 can substitute for the
myosin V protein absent from the dilute mice, Myr6 does
not appear to be capable of fulfilling all its functions, as
evidenced by the defects in coat colour and the premature
death by nervous seizures shown by the dilute phenotype.
The specificity of the CALI technique for its target pro-
teins is illustrated by the fact that CALI of several differ-
ent cytoskeletal proteins in DRGs has quite different
effects. For example, CALI of myosin Ib results in lamel-
lipodial expansion but not filopodial retraction [24]. It is
worth considering how CALI may inactivate the target
protein in situ. In the case of myosin V, a specific antibody
directed against the carboxy-terminal tail region was used.
The MG-conjugated form of this antibody inactivated
both the biochemical activity of purified myosin V and its
ability to generate motility in vitro following irradiation
[24]. But how could the antibody directed against the tail
region of myosin V inactivate the activity of the motor
domain? This remains to be determined, but it is unlikely
that this occurs by irradiation-induced cleavage of the
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Figure 2
The inactivation of myosin V by CALI in the
nerve growth-cone. This figure shows a nerve
growth-cone and the distribution of selected
cytoskeletal elements (microtubules, actin and
myosin V). The terminus of the growth cone is
rich in actin, and the central region is
predominantly composed of microtubules.
Myosin V can attach to vesicles that are
carried along the microtubules by kinesin, with
myosin V acting as a passenger (1); and
myosin V can also be found in the periphery of
the nerve attached to a vesicle (2).
Microinjection of chromophore-labeled anti-
myosin V antibody followed by irradiation of
the growth cone would presumably disrupt
myosin V function exclusively at the outermost
portions of the growth cone (2). Alternatively,
the myosin V tail could be in close proximity to
the presumptive microtubule motor, the
function of which would then also be affected
following irradiation (3).
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heavy chain. Also, if myosin V is present as part of a ‘trans-
port complex’, it is not possible to rule out the possibility
that the antibody can inactivate another protein that is in
close enough proximity to the tail of myosin V (which is
presumably binding to the cargo) to be affected by the
CALI treatment (Fig. 2). The observation that myosin V-
associated vesicles are localized to microtubules in addi-
tion to actin filaments [17] suggests that this may be the
case. Myosin V could be a passive cargo on kinesin-trans-
ported vesicles and, if the MG-antibody were close
enough, it could also damage the microtubule-based trans-
port system that routes material to the extending growth
cone. While many interesting questions remain, it is clear
that the CALI effect is specific and that myosin V is either
directly involved or in intimate contact with proteins that
play a key role in the extension of filopodia.
Taken together, the collective analyses of myosin V
strongly implicate this unconventional myosin in the
directed delivery of material to the periphery of cells.
Whether this material is exclusively in the form of a mem-
brane-bound organelle, a complex of proteins or even
mRNA molecules, remains to be determined. The mount-
ing evidence suggests that myosin V participates in the
transport of a wide range of materials and that it may not
be a ‘dedicated’ motor protein, that is, it may not be
restricted to the movement of one specific class of mole-
cules or organelles. It is also needs to be clearly estab-
lished whether myosin V is directly transporting these
materials or if it is organizing the state of the underlying
actin cytoskeleton to facilitate or optimize the transport of
the materials by other proteins. The next step is to charac-
terize myosin V’s partners in crime — tail-binding pro-
teins that anchor myosin V either to its cargo or to its
intracellular location. The identification of distinct mem-
brane-bound organelles that possess myosin V [19,21], the
ability to obtain biochemical quantities of this protein
[3,4] and the availability of myosin V mutants in a geneti-
cally tractable system [5,13,16] hold the promise of rapid
progress towards this goal. 
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